Katina Health Group was founded in 197 1, then it was called Katina Food Company, and its business activities were mainly carried out in Columbus and Ohio. At present, Cardina Health Group has become a large-scale service provider in the health care industry, serving customers through rich resources and professional knowledge, from producing health care products to providing facilities needed for nursing patients to meet customers' needs. The founder of Cartina is Robert D. Walter, who successfully led the transformation of Cartina. He is still the chairman and CEO of Cartina.
Cardina Health Group was mainly engaged in the food industry at the beginning of its establishment and eventually became a leader in this field. However, by 1979, the American food sales business was merged into several large domestic food companies, which limited the continued development of the group. Walter and his collaborators turned their attention to the drug sales with great development prospects, so Katina bought a drug sales company in Zanesville, Ohio, 60 miles from Columbus, and later developed into a Katina sales company, marking Katina's formal entry into the American drug sales industry.
1983, Cardina founded a public enterprise, partly to accumulate capital and expand the rapidly developing drug sales business. In the past ten years, the group has acquired more than a dozen drug sales companies in the United States. From 65438 to 0987, drug sales almost doubled to food sales.
1988, Kadina sold the department responsible for food sales, and completely transferred the group's business to drug sales.
199 1 year, Cardina's operating income reached 1 billion dollars for the first time.
From 65438 to 0994, Cardina established an absolute leading position in the field of drug sales, covering the whole country, with an annual income of about 6 billion US dollars.
1999, Cartina acquired Libriafite Animal Medicine International Company and formally entered the animal medicine business. After that, Cardina not only began to sell drugs, but also acquired some companies that operated health care products and patient care facilities, including Pyxis, which operated automatic supply and drug sales, Owen Health Care, which managed hospital drugs, Shoppe, an international drug company with exclusive drug management rights, R.P. scherer, who developed and cooperated in the production of drug transportation channels, and Allegiance, which produced and sold surgical medical products. In this way, Cartier repositioned the company's business as health care, which has a sustainable development prospect in this field.
In 2003, Cartier Health Group entered the health care industry in China, Hongkong, Taiwan Province and Macau.
In 2007, Katina Health Group ranked 51st in the global ranking of Fortune magazine.
In 2009, the turnover of Katina Health Group was close to $654.38 billion.
In 20 10, Cartina Health Group ranked 43rd in the list of the top 500 in the world. In the same year, Cardina acquired Yongyu Pharmaceutical Management Company, one of the largest drug importers in China, for US$ 470 million to expand its business in China. This acquisition is also the first major investment by a large American pharmaceutical wholesale enterprise in Asia.
In the September quarter of 20 1 1, Cartier Health Group achieved a net profit of $236.8 million.
Today, Cartina Health Group can provide customers with advanced products and services to meet the challenges brought by this development field.